However, few studies have also supported either comparable circulating OPG levels between patients with and without NAFLD [23, 96] or increased serum OPG levels in NAFLD patients when compared to non-NAFLD individuals [97]. This evidence concerns the gene TNFRSF11B and metabolic dysfunction-associated steatotic liver disease.